Related Experiment Video

Updated: Mar 24, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

903

MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia

Chiranjib Chakraborty1,2, Ashish Ranjan Sharma1, Bidhan Chandra Patra3

  • 1Institute for Skeletal Aging & Orthopedic Surgery, Hallym University-Chuncheon Sacred Heart Hospital, Chuncheon, 200704, Korea.

Oncotarget
|March 12, 2016
PubMed

Insights

MicroRNAs (miRNAs) regulate the Mitogen-activated protein kinase (MAPK) signaling pathway, offering potential new therapeutic targets for chronic myeloid leukemia (CML) treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Chronic myeloid leukemia (CML) is a significant global health issue requiring novel therapeutic strategies.
  • The Mitogen-activated protein kinase (MAPK) signaling pathway is vital for cell survival and its dysregulation is implicated in cancer.
  • MicroRNAs (miRNAs) are key regulators of gene expression with emerging roles in various cancers, including CML.

Purpose of the Study:

  • To explore the regulatory roles of miRNAs in the MAPK signaling pathway in the context of CML.
  • To identify specific miRNAs that modulate key protein cascades within the MAPK pathway relevant to CML.

Main Methods:

  • Literature review of studies investigating miRNA involvement in MAPK signaling in CML.
  • Analysis of reported interactions between specific miRNAs and proteins in the MAPK pathway.

Main Results:

  • Several miRNAs (e.g., miR-203, miR-196a, miR-126, miR-155) were identified as regulators of MAPK pathway proteins, including BCR-ABL tyrosine kinase, CRK family proteins, SOS, KRAS, RAF1, and MAPK/ERK.
  • These miRNAs were shown to either elevate or suppress the expression of these critical proteins.

Conclusions:

  • miRNAs play a significant role in controlling MAPK signaling pathway protein cascades.
  • Understanding miRNA-mediated regulation of MAPK signaling presents promising avenues for developing novel CML therapeutic targets.
Keywords:
MAPKchronic myeloid leukemiamicroRNAoncogenicsignaling pathway

More Related Videos

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

9.0K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.0K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K